University Amedeo Avogadro Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2005
NCT00210340
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

International Extranodal Lymphoma Study Group/Hematology Division. University Amedeo Avogadro. Novara | Università degli Studi del Piemonte Orientale "Amedeo Avogadro"